5 May 2016 - Proposal aims to cut doctors’ incentives to prescribe costly drugs for ills such as cancer.

An Obama administration proposal to reduce Medicare’s profit incentives to doctors who administer drugs is drawing such intense congressional criticism that some policy analysts question whether it will survive intact.

Dozens of House Republicans are demanding the proposal be withdrawn, and Democrats on the Senate Finance Committee are raising concerns with the Centers for Medicare and Medicaid Services, which administers the program. The pushback is growing in advance of a May 9 deadline for public comments.

“They may have underestimated the strength and power of the opposition to the changes,” said Tricia Neuman, a senior vice president at the Kaiser Family Foundation. “This seems to be an all-out war, so it’s hard to know how it will play out.”

For more details, go to: http://www.wsj.com/articles/lawmakers-criticize-medicare-plan-for-costly-drugs-1462491672